Epetraborole, a leucyl-tRNA synthetase inhibitor, demonstrates murine efficacy, enhancing the in vivo activity of ceftazidime against Burkholderia pseudomallei, the causative agent of melioidosis

• Jason E. Cummings,

  Roles Formal analysis, Investigation, Methodology, Project administration, Writing – original draft, Writing – review & editing

  Affiliation Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, United States of America

  ⨯
• Christopher S. Lunde,

  Roles Formal analysis, Project administration, Writing – original draft, Writing – review & editing

  Affiliation AN2 Therapeutics, Menlo Park, California, United States of America

  ⨯
• M. R. K. Alley,

  Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Project administration, Writing – original draft, Writing – review & editing

  Affiliation AN2 Therapeutics, Menlo Park, California, United States of America

  ⨯
• Richard A. Slayden

  Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Project administration, Resources, Supervision, Writing – original draft, Writing – review & editing

  * E-mail: richard.slayden@colostate.edu

  Affiliation Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, United States of America

  https://orcid.org/0000-0001-6857-7277

  ⨯